Pfizer Covid-19 vaccine gets emergency use authorisation in Bangladesh

The Directorate General of Drug Administration (DGDA) has issued emergency use authorisation (EUA) to the Pfizer mRNA Covid-19 vaccine in the country today.

The EUA was issued as per recommendation of the committee for the evaluation of drug, investigational drug, vaccine and medical device in case of public health emergency, said a press release signed by Maj Gen Md Mahbubur Rahman, director general of DGDA.

Produced by Pfizer Manufacturing Belgium NV, this is the fourth Covid-19 vaccine approved for emergency use in Bangladesh.

The other approved vaccines are: Covishield produced by Serum Institute of India, Sputnik V produced by Generium Joint Stock Company of Russia, and Sinopharm produced by Beijing Institute of Biological Products Co. Ltd of China.